HERINGS is a companion digital therapeutics company aiming to enhance  life integrity against serious chronic diseases especially in oncology. HERINGS incorporates extensive therapeutic knowledge, clinical research expertise and comprehensive innovative technology for developing novel solutions. HERINGS integrates two core platforms in designing its solution pipelines: CRAIMON, an AI embedded algorithm development platform and RHEXIUM, a technology platform transforming clinical decision rules to smart digitalized solutions. The leading products include a solution for post-gastrectomy syndrome and a compliance management solution for chemotherapy induced adverse events.